- Home
- WOOF vs VALN Comparison
WOOF vs VALN Comparison
Compare WOOF & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- VALN
- Stock Information
- Founded
- WOOF 1965
- VALN 2012
- Country
- WOOF United States
- VALN France
- Employees
- WOOF N/A
- VALN N/A
- Industry
- WOOF Other Specialty Stores
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WOOF Consumer Discretionary
- VALN Health Care
- Exchange
- WOOF Nasdaq
- VALN Nasdaq
- Market Cap
- WOOF 986.5M
- VALN 820.0M
- IPO Year
- WOOF 2021
- VALN 2021
- Fundamental
- Price
- WOOF $3.16
- VALN $9.05
- Analyst Decision
- WOOF Hold
- VALN Strong Buy
- Analyst Count
- WOOF 11
- VALN 4
- Target Price
- WOOF $3.91
- VALN $15.75
- AVG Volume (30 Days)
- WOOF 2.1M
- VALN 29.5K
- Earning Date
- WOOF 12-04-2025
- VALN 11-20-2025
- Dividend Yield
- WOOF N/A
- VALN N/A
- EPS Growth
- WOOF N/A
- VALN N/A
- EPS
- WOOF N/A
- VALN N/A
- Revenue
- WOOF $6,045,495,000.00
- VALN $230,566,060.00
- Revenue This Year
- WOOF N/A
- VALN $15.69
- Revenue Next Year
- WOOF $0.98
- VALN $22.15
- P/E Ratio
- WOOF N/A
- VALN N/A
- Revenue Growth
- WOOF N/A
- VALN 25.47
- 52 Week Low
- WOOF $2.28
- VALN $3.62
- 52 Week High
- WOOF $6.29
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- WOOF 35.06
- VALN 36.90
- Support Level
- WOOF $3.10
- VALN $10.08
- Resistance Level
- WOOF $3.87
- VALN $9.57
- Average True Range (ATR)
- WOOF 0.16
- VALN 0.23
- MACD
- WOOF -0.06
- VALN -0.14
- Stochastic Oscillator
- WOOF 9.74
- VALN 2.60
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.